{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:25:25Z","timestamp":1792113925028,"version":"4.4.0"},"reference-count":203,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.clindermatol.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T14:02:22Z","timestamp":1593180142000},"page":"679-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions"],"prefix":"10.1016","volume":"38","author":[{"given":"Shayan","family":"Cheraghlou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren L.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2020.06.010_bb0005","first-page":"765","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0010","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaad.2012.12.949","article-title":"Pediatric dermatology inpatient consultations: a retrospective study of 427 cases","volume":"68","author":"McMahon","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0015","doi-asserted-by":"crossref","unstructured":"Davila M, Christenson LJ, Sontheimer RD. Epidemiology and outcomes of dermatology in-patient consultations in a Midwestern U.S. university hospital. Dermatol Online J. 2010;16:12.","DOI":"10.5070\/D364H8J3KZ"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaad.2009.06.030","article-title":"Dermatology inpatient consultations: a retrospective study","volume":"62","author":"Bauer","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.det.2007.08.010","article-title":"Cutaneous reactions related to systemic immunomodulators and targeted therapeutics","volume":"26","author":"Hammond-Thelin","year":"2008","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jaad.2017.12.031","article-title":"Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients","volume":"78","author":"Phillips","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2010.06.051","article-title":"The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies","volume":"65","author":"Balagula","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","volume":"20","author":"Brahimi","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0190-9622(87)70220-5","article-title":"Nonpigmenting fixed drug eruption as a distinctive reaction pattern: examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline","volume":"17","author":"Shelley","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2133.1989.tb01337.x","article-title":"Fixed drug eruptions: 77 cases from 1981 to 1985","volume":"120","author":"Stubb","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0055","series-title":"UpToDate","article-title":"Fixed drug eruption","author":"Shiohara","year":"2020"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0060","series-title":"Dermatology","first-page":"348","article-title":"Drug reactions","author":"Valeyrie-Allanore","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0065","first-page":"50","article-title":"Fixed drug eruption in a mother and her son","volume":"50","author":"Hatzis","year":"1992","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0190-9622(96)90698-2","article-title":"Fixed food eruption","volume":"35","author":"Kelso","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1440-0960.1997.tb01701.x","article-title":"Fixed drug eruption to tartrazine","volume":"38","author":"Orchard","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaip.2014.08.004","article-title":"Fixed food eruption caused by peanut and cashew: a case report and review of the literature","volume":"3","author":"Parker","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0085","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000443949","article-title":"Fixed drug eruption due to achiote dye","volume":"8","author":"Tattersall","year":"2016","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0090","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.1987.tb05849.x","article-title":"Fixed drug eruption: an immunohistochemical investigation of the acute and healing phase","volume":"116","author":"Hindsen","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0100","first-page":"550","article-title":"Drug-induced expression of intercellular adhesion molecule-1 on lesional keratinocytes in fixed drug eruption","volume":"145","author":"Teraki","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0105","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)64410-0","article-title":"Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption","volume":"161","author":"Mizukawa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0110","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.4049\/jimmunol.165.4.1910","article-title":"do Couto LMR, Leusen JH, et al. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+ CD45RA+ CD27\u2212 human T cells","volume":"165","author":"Baars","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0115","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0120","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2008.08516.x","article-title":"In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption","volume":"158","author":"Mizukawa","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0125","first-page":"207","article-title":"Fixed drug eruption due to doxycycline and metronidazole","volume":"69","author":"Walfish","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0130","first-page":"591","article-title":"Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole","volume":"16","author":"Ozkaya","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0135","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/ACI.0b013e32832cda4c","article-title":"Fixed drug eruption: pathogenesis and diagnostic tests","volume":"9","author":"Shiohara","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0140","series-title":"Dermatology","first-page":"527","article-title":"Dermatitis herpetiformis and linear IgA bullous dermatosis","author":"Hull","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0145","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature","volume":"30","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0155","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/archderm.1988.01670080012007","article-title":"Vancomycin-induced linear IgA bullous dermatosis","volume":"124","author":"Baden","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0190-9622(92)70004-Y","article-title":"Vancomycin-associated linear IgA dermatosis. A report of three cases","volume":"26","author":"Carpenter","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0165","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.1995.01690240113019","article-title":"A bullous eruption in an elderly woman. Vancomycin-associated linear IgA dermatosis (LAD)","volume":"131","author":"Richards","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-129-6-199809150-00021","article-title":"Vancomycin-associated linear IgA bullous dermatosis","volume":"129","author":"Nousari","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0175","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1067\/mjd.2003.116","article-title":"Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis","volume":"48","author":"Dellavalle","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0180","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-4632.2006.02752.x","article-title":"Vancomycin-associated linear IgA bullous dermatosis mimicking toxic epidermal necrolysis","volume":"45","author":"Coelho","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1590\/abd1806-4841.20164665","article-title":"Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis","volume":"91","author":"Pereira","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/bjd.12720","article-title":"A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the alpha3 subunit of laminin-332","volume":"170","author":"Zenke","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-4362.1987.tb02292.x","article-title":"Linear IgA bullous dermatosis mimicking erythema multiforme in adult","volume":"26","author":"Argenyi","year":"1987","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0200","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2133.2006.07315.x","article-title":"Linear IgA disease presenting as prurigo nodularis","volume":"155","author":"Torchia","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0205","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI114508","article-title":"Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis","volume":"85","author":"Zone","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1523-1747.1998.00129.x","article-title":"The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2","volume":"110","author":"Zone","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0215","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.0303-6987.2004.00190.x","article-title":"Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme","volume":"31","author":"Armstrong","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0220","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1111\/ijd.12047","article-title":"A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180","volume":"53","author":"Tashima","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0225","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2001.04492.x","article-title":"Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285","volume":"145","author":"Palmer","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.1991.tb00425.x","article-title":"Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults","volume":"124","author":"Wojnarowska","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2133.1998.02081.x","article-title":"Drug-induced linear IgA disease with antibodies to collagen VII","volume":"138","author":"Wakelin","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0240","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2133.1998.02453.x","article-title":"The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting","volume":"139","author":"Zhou","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0245","series-title":"Dermatology","first-page":"510","article-title":"Pemphigoid group","author":"Bernard","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0250","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.1984.01650450078023","article-title":"Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study","volume":"120","author":"Kashihara","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0255","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0260","first-page":"562","article-title":"Furosemide-induced bullous pemphigoid: case report and review of literature","volume":"5","author":"Lee","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0265","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0190-9622(88)70050-X","article-title":"Bullous pemphigoid mimicking bullous erythema multiforme: an untoward side effect of penicillins","volume":"18","author":"Alcalay","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2133.2000.03389.x","article-title":"Pemphigoid nodularis associated with nifedipine","volume":"142","author":"Ameen","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/106002808902300115","article-title":"Bullous pemphigoid associated with captopril","volume":"23","author":"Mallet","year":"1989","journal-title":"DICP"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0190-9622(88)70156-5","article-title":"Pemphigoid-like bullous eruption related to ibuprofen","volume":"19","author":"Laing","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0285","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1468-3083.2011.04062.x","article-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","volume":"26","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0290","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jamadermatol.2013.1073","article-title":"A case report of bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors","volume":"149","author":"Aouidad","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0295","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jid.2018.01.027","article-title":"vildagliptin significantly increases the risk of bullous pemphigoid: a Finnish nationwide registry study","volume":"138","author":"Varpuluoma","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0300","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2017.12.038","article-title":"Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: retrospective multicenter case-control study from France and Switzerland","volume":"78","author":"Benzaquen","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/CMR.0000000000000155","article-title":"A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab","volume":"25","author":"Carlos","year":"2015","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0310","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/CMR.0000000000000260","article-title":"Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies","volume":"26","author":"Hwang","year":"2016","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0315","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/CCO.0000000000000290","article-title":"Dermatologic complications of anti-PD-1\/PD-L1 immune checkpoint antibodies","volume":"28","author":"Sibaud","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0320","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaad.2018.07.008","article-title":"Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: a retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy","volume":"79","author":"Siegel","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0325","doi-asserted-by":"crossref","unstructured":"Zumelzu C, Alexandre M, Le Roux C, et al. Mucous membrane pemphigoid, bullous pemphigoid, and anti-programmed death-1\/ programmed death-ligand 1: a case report of an elderly woman with mucous membrane pemphigoid developing after pembrolizumab therapy for metastatic melanoma and review of the literature. Front Med (Lausanne). 2018;5:268.","DOI":"10.3389\/fmed.2018.00268"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0330","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archderm.1987.01660270127031","article-title":"Localized bullous pemphigoid: a mimic of acute contact dermatitis","volume":"123","author":"Salomon","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2011.03.005","article-title":"Bullous pemphigoid: from the clinic to the bench","volume":"30","author":"Di Zenzo","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0340","first-page":"1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid","volume":"134","author":"Vaillant","year":"1998","journal-title":"French Bullous Study Group Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0345","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000075040","article-title":"Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera","volume":"208","author":"Joly","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0350","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1067\/mjd.2002.107774","article-title":"Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagen","volume":"46","author":"Delbaldo","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0355","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/eye.1998.66","article-title":"Drug-induced ocular cicatricial pemphigoid: a series of clinico-pathological reports","volume":"12","author":"Butt","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0360","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2340\/00015555-0117","article-title":"Penicillin-induced anti-p200 pemphigoid: an unusual morphology","volume":"86","author":"Wozniak","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archderm.1970.04000080077015","article-title":"Bullous pemphigoid in an 11-year-old boy","volume":"102","author":"Bean","year":"1970","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0370","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-4632.2009.03839.x","article-title":"Medication history of a series of patients with bullous pemphigoid from northern Greece\u2014observations and discussion","volume":"48","author":"Patsatsi","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0375","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0968-0004(93)90022-F","article-title":"Autoimmune disease and molecular mimicry: an hypothesis","volume":"18","author":"Baum","year":"1993","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0380","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0738-081X(98)00008-X","article-title":"Drug-induced pemphigoid: bullous and cicatricial","volume":"16","author":"Vassileva","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0385","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-4362.1991.tb03867.x","article-title":"Pemphigus and bullous pemphigoid due to drugs","volume":"30","author":"Ruocco","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0390","first-page":"601","article-title":"Immunogenetics of drug-induced skin blistering disorders","volume":"10","author":"Bowman","year":"2009","journal-title":"Part I: perspective Pharmacogenomics"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0395","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0141-8130(05)80004-2","article-title":"Comparative structural analysis of desmoplakin, bullous pemphigoid antigen and plectin: members of a new gene family involved in organization of intermediate filaments","volume":"14","author":"Green","year":"1992","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0400","doi-asserted-by":"crossref","first-page":"17784","DOI":"10.1016\/S0021-9258(18)55195-4","article-title":"Human bullous pemphigoid antigen (BPAG1). Amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains","volume":"266","author":"Sawamura","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0405","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1242\/jcs.00241","article-title":"Analysis of the interactions between BP180, BP230, plectin and the integrin \u03b16\u03b24 important for hemidesmosome assembly","volume":"116","author":"Koster","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0410","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.matbio.2010.10.005","article-title":"Type XVII collagen (BP180) can function as a cell\u2212 matrix adhesion molecule via binding to laminin 332","volume":"30","author":"Van den Bergh","year":"2011","journal-title":"Matrix Biol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0415","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1172\/JCI115054","article-title":"Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180","volume":"87","author":"Giudice","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0420","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1523-1747.ep12616615","article-title":"Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization","volume":"99","author":"Hopkinson","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0425","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/jid.2010.19","article-title":"A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex","volume":"130","author":"Groves","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0430","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI117785","article-title":"180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa","volume":"95","author":"Jonkman","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0435","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng0995-83","article-title":"Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa","volume":"11","author":"McGrath","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0440","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls","volume":"102","author":"B\u00fcdinger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0445","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0450","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0455","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.1977.01640110040004","article-title":"Oral pemphigus vulgaris: a report of ten cases","volume":"113","author":"Meurer","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0460","series-title":"Dermatology","first-page":"494","article-title":"Pemphigus","author":"Amagai","year":"2018"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0465","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archderm.1970.04000100019005","article-title":"Pemphigus vulagis involving the esophagus","volume":"102","author":"Raque","year":"1970","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0470","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0190-9622(81)70070-7","article-title":"Esophagitis dissecans superficialis associated with pemphigus vulgaris","volume":"4","author":"Kaplan","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0475","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0190-9622(89)70309-1","article-title":"Pemphigus vulgaris of the esophagus in women","volume":"21","author":"Goldberg","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0480","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0190-9622(91)70031-V","article-title":"Esophageal involvement in pemphigus vulgaris: a clinical, histologic, and immunopathologic study","volume":"24","author":"Trattner","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0485","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archderm.1975.01630230086018","article-title":"Pemphigus involving the eyes","volume":"111","author":"Bean","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0490","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1990.tb01478.x","article-title":"Conjunctival involvement in pemphigus vulgaris: a clinical, histopathological and immunofluorescence study","volume":"123","author":"Hodak","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0495","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s10350-005-0294-3","article-title":"Anal involvement in pemphigus vulgaris","volume":"49","author":"Malik","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0500","first-page":"609181","article-title":"Anal involvement in pemphigus vularis","volume":"2013","author":"Khezri","year":"2013","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0505","first-page":"756","article-title":"Penile pemphigus","volume":"137","author":"Sami","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0510","doi-asserted-by":"crossref","unstructured":"Healy WJ, Peters S, Nana-Sinkam SP. A middle-aged man presenting with unexplained mucosal erosions and progressive dyspnoea. BMJ Case Rep. 2015;2015:bcr2014208677.","DOI":"10.1136\/bcr-2014-208677"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0515","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.AOG.0000185258.74177.91","article-title":"Involvement of the female genital tract in pemphigus vulgaris","volume":"106","author":"Malik","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0520","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archderm.134.11.1485","article-title":"Pemphigus vulgaris of the cervix and upper vaginal vault: a cause of atypical Papanicolaou smears","volume":"134","author":"Chan","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0525","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2133.1999.02832.x","article-title":"Pemphigus vulgaris localized to the vagina presenting as chronic vaginal discharge","volume":"140","author":"Batta","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0530","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2230.2000.00622.x","article-title":"An unusual case of pemphigus vulgaris presenting as bilateral foot ulcers","volume":"25","author":"Tan","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0535","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1067\/mjd.2000.106236","article-title":"Nail involvement in pemphigus vulgaris","volume":"43","author":"Engineer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0540","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2230.1996.tb00107.x","article-title":"Paronychia\u2013a manifestation of pemphigus vulgaris","volume":"21","author":"Kim","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0545","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D34X15T5FK","article-title":"Pemphigus vulgaris presenting as an isolated crusted plaque of the cheek","volume":"15","author":"Khelifa","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0550","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D346K7H973","article-title":"Localized pemphigus with vegetative features","volume":"18","author":"Lehrhoff","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0555","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/archderm.1985.01660100108028","article-title":"Macroglossia: an unusual presentation of pemphigus vulgaris","volume":"121","author":"Milgraum","year":"1985","journal-title":"Arch Dermatol"},{"issue":"suppl 3","key":"10.1016\/j.clindermatol.2020.06.010_bb0560","first-page":"103","article-title":"Penicillamine-induced pemphigus","volume":"70","author":"Marsden","year":"1977","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0565","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.2.6049.1423","article-title":"Pemphigus foliaceus induced by penicillamine","volume":"2","author":"Marsden","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0570","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0190-9622(98)70426-8","article-title":"D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1","volume":"39","author":"Brenner","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0575","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bmj.281.6234.194","article-title":"Captopril-induced pemphigus","volume":"281","author":"Parfrey","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0580","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/1523-1747.ep12464471","article-title":"Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus","volume":"96","author":"Korman","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0585","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1590\/abd1806-4841.20153390","article-title":"Mucosal-dominant pemphigus vulgaris in a captopril-taking woman with angioedema","volume":"90","author":"Gornowicz-Porowska","year":"2015","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0590","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/000155500750043078","article-title":"Pemphigus vulgaris possibly triggered by Cilazapril","volume":"80","author":"Orion","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0595","first-page":"153","article-title":"Pemphigus vulgaris triggered by glibenclamide and cilazapril","volume":"13","author":"Goldberg","year":"2005","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0600","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/000155598441639","article-title":"Pemphigus foliaceus associated with cilazapril","volume":"78","author":"Buzon","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0605","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0714.1993.tb00051.x","article-title":"Pemphigus vulgaris precipitated by glibenclamide therapy","volume":"22","author":"Paterson","year":"1993","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0610","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2340\/000155555573210211","article-title":"Pemphigus foliaceus induced by nifedipine","volume":"73","author":"Kim","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0615","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0190-9622(97)80238-1","article-title":"Dipyrone in the induction of pemphigus","volume":"36","author":"Brenner","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0620","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1540-9740.2004.03343.x","article-title":"Pemphigus vulgaris triggered by rifampin and emotional stress","volume":"3","author":"Goldberg","year":"2004","journal-title":"Skinmed"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0625","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1046\/j.1365-4362.1999.00836.x","article-title":"The induction of pemphigus by phenol drugs","volume":"38","author":"Goldberg","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0630","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.140.7.889","article-title":"Localized pemphigus foliaceus induced by topical imiquimod treatment","volume":"140","author":"Lin","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0635","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0301-2115(02)00482-7","article-title":"Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect","volume":"109","author":"Campagne","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0640","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1473-2130.2004.00098.x","article-title":"Pemphigus can be induced by topical phenol as well as by foods and drugs that contain phenols or thiols","volume":"2","author":"Brenner","year":"2003","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0645","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000245685","article-title":"Diclofenac: a new trigger of pemphigus vulgaris?","volume":"195","author":"Matz","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0650","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-4362.1994.tb01016.x","article-title":"Contact pemphigus: a subgroup of induced pemphigus","volume":"33","author":"Brenner","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0655","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2133.2000.03538.x","article-title":"The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus","volume":"142","author":"Harman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0660","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1365-2133.2001.04312.x","article-title":"The use of two substrates for indirect immunofluorescence in the diagnosis of pemphigus","volume":"145","author":"Jarzabek-Chorzelska","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0665","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archderm.135.2.143","article-title":"Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool","volume":"135","author":"Lenz","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0670","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2133.1999.02752.x","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus","volume":"140","author":"Amagai","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0675","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2230.2000.00624.x","article-title":"Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3","volume":"25","author":"Harman","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0680","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0685","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0690","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1523-1747.1998.00085.x","article-title":"Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1","volume":"110","author":"Shirakata","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0695","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM200007063430105","article-title":"Protection against pemphigus foliaceus by desmoglein 3 in neonates","volume":"343","author":"Wu","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0700","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1523-1747.2002.01780.x","article-title":"Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion","volume":"119","author":"Hanakawa","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0705","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI117349","article-title":"Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus","volume":"94","author":"Amagai","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0710","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI115968","article-title":"Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic","volume":"90","author":"Amagai","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0715","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0720","first-page":"1","article-title":"Identification of desmoglein, a constitutive desmosomal glycoprotein, as a member of the cadherin family of cell adhesion molecules","volume":"53","author":"Koch","year":"1990","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0725","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1083\/jcb.138.1.193","article-title":"Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion","volume":"138","author":"Chitaev","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0730","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1074\/jbc.M512447200","article-title":"Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies","volume":"281","author":"Calkins","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050696","article-title":"Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation","volume":"7","author":"Saito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0740","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/archderm.1989.01670220063009","article-title":"Induction of acantholysis in organ explant culture by penicillamine and captopril","volume":"125","author":"Yokel","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0745","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000248686","article-title":"In vitro acantholysis by captopril and thiopronine","volume":"176","author":"Ruocco","year":"1988","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0750","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000250097","article-title":"Pemphigus provoked by D(-)penicillamine. An experimental approach using in vitro tissue cultures","volume":"164","author":"Ruocco","year":"1982","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0755","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0560.1992.tb01656.x","article-title":"In vitro acantholysis induced by D-penicillamine, captopril, and piroxicam on dead de-epidermized dermis","volume":"19","author":"De Dobbeleer","year":"1992","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0760","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000247795","article-title":"Drug-induced versus drug-triggered pemphigus","volume":"182","author":"Wolf","year":"1991","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0765","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clindermatol.2011.01.016","article-title":"Drug-induced pemphigus","volume":"29","author":"Brenner","year":"2011","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0770","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2133.1983.tb04596.x","article-title":"Specific incorporation of penicillamine into the epidermis of mice: an autoradiographic study","volume":"108","author":"Ruocco","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0775","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0738-081X(98)00010-8","article-title":"Drug-induced pemphigus","volume":"16","author":"Brenner","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0780","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1523-1747.2000.00056.x","article-title":"Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate","volume":"115","author":"Newby","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0785","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1\u03b1 and tumor necrosis factor-\u03b1 mRNA in pemphigus vulgaris: interleukin-1\u03b1 and tumor necrosis factor-\u03b1 are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0790","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12277087","article-title":"Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor","volume":"92","author":"Hashimoto","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0795","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archderm.1977.01640050070009","article-title":"Bullous pemphigoid responding to sulfapyridine and the sulfones","volume":"113","author":"Person","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0800","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-97-2-165","article-title":"Bullous eruption of systemic lupus erythematosus: dramatic response to dapsone therapy","volume":"97","author":"Hall","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0805","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.1982.tb00360.x","article-title":"Linear IgA disease in adults","volume":"107","author":"Leonard","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0810","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/1523-1747.ep12471811","article-title":"Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses","volume":"100","author":"Thuong-Nguyen","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0815","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2230.2004.01649.x","article-title":"Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis","volume":"29","author":"Waldman","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0820","doi-asserted-by":"crossref","DOI":"10.2337\/dc11-0804","article-title":"Dipeptidyl peptidase-4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases","volume":"34","author":"Pasmatzi","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0825","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000207792","article-title":"Bullous pemphigoid occurring during efalizumab treatment for psoriasis: a paradoxical auto-immune reaction?","volume":"219","author":"Monnier-Murina","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0830","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1345\/aph.1D013","article-title":"Oral terbinafine-induced bullous pemphigoid","volume":"37","author":"Aksakal","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0835","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0738-081X(93)90164-8","article-title":"Drug-induced blistering oral lesions","volume":"11","author":"Laskaris","year":"1993","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0840","series-title":"UpToDate","article-title":"Lichenoid drug eruption (drug-induced lichen planus)","author":"Ziemer","year":"2020"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0845","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0190-9622(93)70176-T","article-title":"Lichenoid drug eruptions","volume":"29","author":"Halevy","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0850","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0190-9622(81)70025-2","article-title":"Quinacrine hydrochloride drug eruption (tropical lichenoid dermatitis). Its early and late sequelae and its malignant potential: a review","volume":"4","author":"Bauer","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0855","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archderm.1981.01650030018010","article-title":"Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis","volume":"117","author":"Seehafer","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0860","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0190-9622(83)70166-0","article-title":"Primary biliary cirrhosis and lichen planus","volume":"9","author":"Powell","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0865","first-page":"549","article-title":"Side effects of beta receptor blockers on the skin. Review and personal observations","volume":"36","author":"Hodl","year":"1985","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0870","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000075054","article-title":"Spontaneous tolerance to terbinafine-induced lichenoid drug eruption","volume":"208","author":"Teraki","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0875","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-0960.1989.tb00400.x","article-title":"Drug eruptions with lichenoid histology produced by captopril","volume":"30","author":"Rotstein","year":"1989","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0880","first-page":"98","article-title":"Lichenoid eruption produced by captopril","volume":"31","author":"Reinhardt","year":"1983","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0885","first-page":"41","article-title":"Lichenoid drug eruption secondary to propranolol","volume":"48","author":"Massa","year":"1991","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0890","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0190-9622(97)70036-7","article-title":"Lichenoid dermatitis after consumption of gold-containing liquor","volume":"36","author":"Russell","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0895","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000251461","article-title":"Lichenoid eruption following penicillamine. A case report with some biochemical observations","volume":"150","author":"van de Staak","year":"1975","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0900","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2230.2002.01108.x","article-title":"Thiazide-induced lichenoid photosensitivity","volume":"27","author":"Johnston","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0905","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0030-4220(92)90380-9","article-title":"Ingestion of medication among patients with oral keratoses including lichen planus","volume":"74","author":"Robertson","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0910","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1601-0825.1997.tb00013.x","article-title":"Oral lichenoid drug eruptions","volume":"3","author":"McCartan","year":"1997","journal-title":"Oral Dis"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0915","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1525-1470.2009.00953.x","article-title":"Oral lichenoid drug eruption: a report of a pediatric case and review of the literature","volume":"26","author":"Woo","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0920","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/jid.2009.42","article-title":"Lichenoid tissue reaction\/interface dermatitis: clinical and histological perspectives","volume":"129","author":"Sontheimer","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0925","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000248091","article-title":"Histopathological discriminant criteria between lichenoid drug eruption and idiopathic lichen planus: retrospective study on selected samples","volume":"179","author":"Van den Haute","year":"1989","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0930","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-4632.2011.05113.x","article-title":"Lichen planus and lichenoid drug-induced eruption: a histological and immunohistochemical study","volume":"51","author":"Lage","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0935","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0190-9622(90)70275-M","article-title":"A comparative histopathologic study of photodistributed and nonphotodistributed lichenoid drug eruptions","volume":"23","author":"West","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0940","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00000372-199908000-00008","article-title":"Tumid lupus erythematosus","volume":"21","author":"Ruiz","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0945","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0190-9622(99)70056-3","article-title":"Lupus tumidus","volume":"41","author":"Dekle","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0950","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0190-9622(98)70570-5","article-title":"Keratosis lichenoides chronica","volume":"38","author":"Konstantinov","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0955","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00000372-200606000-00052","article-title":"Keratosis lichenoides chronica: proposal of a concept","volume":"28","author":"Boer","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0960","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1982.tb00933.x","article-title":"Keratosis lichenoides chronica","volume":"106","author":"Ryatt","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0965","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2133.2000.03355.x","article-title":"Autocytotoxic T-cell clones in lichen planus","volume":"142","author":"Sugerman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0970","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.2353\/ajpath.2007.070281","article-title":"Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?","volume":"171","author":"Scheler","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0975","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2133.2005.06999.x","article-title":"Lichen planus is associated with human herpesvirus type 7 replication and infiltration of plasmacytoid dendritic cells","volume":"154","author":"De Vries","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0980","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/jid.2008.251","article-title":"Chemokines in the pathogenesis of lichenoid tissue reactions","volume":"129","author":"Meller","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0985","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0990","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000249200","article-title":"Quinidine-induced lichenoid and eczematous photodermatitis","volume":"174","author":"Wolf","year":"1987","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb0995","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555-0758","article-title":"Lichenoid drug eruption with palmoplantar hyperkeratosis due to imatinib mesylate: a case report and a review of the literature","volume":"90","author":"Kuraishi","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb1000","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1093\/jac\/dks225","article-title":"Lichenoid drug reaction to antituberculosis drugs treated through with topical steroids and phototherapy","volume":"67","author":"Lehloenya","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb1005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D319T833JH","article-title":"Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review","volume":"14","author":"Wahiduzzaman","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb1010","first-page":"465","article-title":"Skin and oral lesions associated to imatinib mesylate therapy","volume":"17","author":"Basso","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clindermatol.2020.06.010_bb1015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0714.2004.00272.x","article-title":"Oral lichenoid drug reaction by lithium in a patient with bipolar disorder","volume":"34","author":"Campisi","year":"2005","journal-title":"J Oral Pathol Med"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X20301437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:42Z","timestamp":1760033862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X20301437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":203,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0738081X20301437"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}